Harlan F. Weisman

Insider Reports History

Entity
Individual
Location
C/O Coronado Biosciences, Inc., 15 New England Executive Park, Burlington, MA
Signature
/s/ Harlan F. Weisman, by Kirk Allen Coleman, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Harlan F. Weisman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
TFF Pharmaceuticals, Inc. President and CEO, Director Common Stock 842K $330K $0.39 Jul 3, 2024 Direct
TFF Pharmaceuticals, Inc. President and CEO, Director Restricted stock units 45K $17.6K $0.39 Apr 18, 2024 Direct
TFF Pharmaceuticals, Inc. President and CEO, Director Stock Options (Right to Buy) 27.5K Jul 3, 2024 Direct

Insider Reports Filed by Harlan F. Weisman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TFFP TFF Pharmaceuticals, Inc. Jul 3, 2024 2 $0 4 Jul 8, 2024 President and CEO, Director
TFFP TFF Pharmaceuticals, Inc. Apr 18, 2024 1 $0 4 Apr 22, 2024 President and CEO, Director
TFFP TFF Pharmaceuticals, Inc. Aug 15, 2023 1 $150K 4 Aug 15, 2023 President and CEO, Director
TFFP TFF Pharmaceuticals, Inc. Mar 10, 2023 1 $132K 4 Mar 13, 2023 President and CEO, Director
TFFP TFF Pharmaceuticals, Inc. Dec 15, 2022 1 $53K 4 Dec 19, 2022 President and CEO, Director
TFFP TFF Pharmaceuticals, Inc. Dec 3, 2022 1 $0 4 Dec 6, 2022 President and CEO, Director
TFFP TFF Pharmaceuticals, Inc. May 18, 2022 2 $38.2K 4 May 20, 2022 Director
TFFP TFF Pharmaceuticals, Inc. May 16, 2022 1 $11.9K 4 May 17, 2022 Director